P4509

Palmitoyl-DL-carnitine chloride

synthetic (organic), ≥98% (TLC), PKC inhibitor, powder

• Synonym(e): DL-Hexadecanoylcarnitine, Hexadecanoyl-DL-carnitine, NSC 628323, ​DL-Palmitoylcarnitine
• Lineare Formel: C₂₃H₄₆NO₄ · Cl
• CAS-Nummer: 6865-14-1
• Molekulargewicht: 436.07
• UNSPSC Code: 12352200
• PubChem Substance ID: 24278634
• NACRES: NA.77
• MDL number: MFCD00063481
• Assay: ≥98% (TLC)
• Form: powder

Eigenschaften

• Produktname: Palmitoyl-DL-carnitine chloride, powder
• biological source: synthetic (organic)
• Quality Segment: 200
• assay: ≥98% (TLC)
• form: powder
• color: white
• solubility: H₂O: 25 mg/mL (with heat or sonication)
• storage temp.: −20°C
• SMILES string: Cl.CCCCCCCCCCCCCCCC(=O)OC(CC(O)=O)C[N](C)(C)C
• InChI: 1S/C23H46NO4.ClH/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(19-22(25)26)20-24(2,3)4;/h21H,5-20H2,1-4H3,(H,25,26);1H
• InChI key: LGVBWSFTXDIBPB-UHFFFAOYSA-N

Beschreibung

Application

Palmitoyl-DL-carnitine chloride has been used to study its effect on inflammatory cytokines and calcium (Ca²⁺) influx, using in vitro models of prostate cancer.

Biochem/physiol Actions

Palmitoyl-DL-carnitine chloride is known to inhibit biofilm formation mediated by Pseudomonas aeruginosa and Escherichia coli. It is a phosphokinase C inhibitor.

Long-chain acylcarnitine and well-known intermediate in mitochondrial fatty acid oxidation. Modifies myocardial levels of high-energy phosphates and free fatty acids in the heart. Increases erythroid colony formation in culture. Reduces surface negative charge of erythrocytes and myocytes. Reported to affect currents and inhibit endothelium-dependent relaxation induced by acetylcholine and substance P in a dose dependent manner by suppressing the intracellular calcium signal transduction in endothelial cells.

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)